Paterson P Y, Semo R, Blumenschein G, Swelstad J
Clin Exp Immunol. 1971 Nov;9(5):595-602.
A patient with chronic mucocutaneous candidiasis and cutaneous anergy has been studied and found to have a circulating plasma factor capable of quenching lymphocyte responses of leucocytes of clinically well donors to monilia and other specific mitogenic stimulants. After instituting systemic amphotericin B therapy, the patient exhibited rapid clearing of cutaneous and mucosal lesions and the plasma inhibitor was no longer demonstrable. Loss of the plasma inhibitor was followed by appearance of strong cutaneous hypersensitivity and leucocyte responses to and streptococcal products. These clinical immunologic studies have pointed meaning in relationship to current views regarding immunologic reconstitution systemic antifungal therapy in treatment of chronic candidiasis.
对一名患有慢性黏膜皮肤念珠菌病和皮肤无反应性的患者进行了研究,发现其循环血浆中有一种因子,能够抑制临床上健康供体白细胞对念珠菌及其他特定促有丝分裂刺激物的淋巴细胞反应。在开始全身两性霉素B治疗后,患者的皮肤和黏膜病变迅速消退,血浆中的抑制剂也不再能检测到。血浆抑制剂消失后,患者出现了强烈的皮肤超敏反应以及白细胞对念珠菌和链球菌产物的反应。这些临床免疫学研究对于当前有关慢性念珠菌病治疗中全身抗真菌治疗免疫重建的观点具有重要意义。